ID30249A - Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah - Google Patents

Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah

Info

Publication number
ID30249A
ID30249A IDW00200101996A ID20011996A ID30249A ID 30249 A ID30249 A ID 30249A ID W00200101996 A IDW00200101996 A ID W00200101996A ID 20011996 A ID20011996 A ID 20011996A ID 30249 A ID30249 A ID 30249A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical composition
therapy symptoms
symptoms
therapy
pharmaceutical
Prior art date
Application number
IDW00200101996A
Other languages
English (en)
Inventor
Mitsuru Shimiyama
Takeshi Watanabe
Naomichi Furudate
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of ID30249A publication Critical patent/ID30249A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW00200101996A 1999-08-09 2000-06-07 Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah ID30249A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22505299 1999-08-09

Publications (1)

Publication Number Publication Date
ID30249A true ID30249A (id) 2001-11-15

Family

ID=16823296

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101996A ID30249A (id) 1999-08-09 2000-06-07 Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah

Country Status (13)

Country Link
US (1) US20060287395A1 (id)
EP (1) EP1203582A4 (id)
KR (1) KR20020016944A (id)
CN (1) CN1192769C (id)
AR (1) AR022348A1 (id)
AU (1) AU5245600A (id)
BR (1) BR0009327A (id)
CA (1) CA2370501C (id)
ID (1) ID30249A (id)
MX (1) MXPA01012794A (id)
TR (1) TR200102583T2 (id)
TW (1) TW567068B (id)
WO (1) WO2001010436A1 (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ532589A (en) * 2001-11-07 2005-02-25 Synthon Bv Tamsulosin tablets
US20060035923A1 (en) * 2002-06-07 2006-02-16 Rian Van Meeteren Overactive bladder treating drug
AU2003260373B2 (en) * 2002-08-14 2008-02-21 Janssen Pharmaceutica N.V. Treatment of lower urinary tract symptoms associated with overactive bladder in men and women
CA2497464A1 (en) * 2002-09-03 2004-03-18 Yamanouchi Pharmaceutical Co., Ltd. A therapeutic agent for improving hypogastric and/or perineal pains
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
CA2697137A1 (en) * 2007-07-20 2009-01-29 Astellas Pharma Inc. Pharmaceutical composition for amelioration of lower urinary tract symptoms associated with prostatomegaly

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
ATE89719T1 (de) * 1989-09-04 1993-06-15 Yamanouchi Pharma Co Ltd Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
ES2172584T3 (es) * 1994-05-18 2002-10-01 Hisamitsu Pharmaceutical Co Preparacion administrable por via percutanea para tratar trastornos de la miccion.
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction

Also Published As

Publication number Publication date
TW567068B (en) 2003-12-21
BR0009327A (pt) 2002-01-22
KR20020016944A (ko) 2002-03-06
CA2370501A1 (en) 2001-02-15
WO2001010436A1 (fr) 2001-02-15
CN1192769C (zh) 2005-03-16
CN1346268A (zh) 2002-04-24
CA2370501C (en) 2008-09-16
AR022348A1 (es) 2002-09-04
US20060287395A1 (en) 2006-12-21
EP1203582A4 (en) 2005-08-03
MXPA01012794A (es) 2002-09-02
EP1203582A1 (en) 2002-05-08
AU5245600A (en) 2001-03-05
TR200102583T2 (tr) 2002-07-22

Similar Documents

Publication Publication Date Title
NO20015175D0 (no) Farmasöytisk sammensetning
FI991485A (fi) Uusi farmaseuttinen koostumus
PT1242087E (pt) Composicoes farmaceuticas
DK1637127T3 (da) Terapeutisk mikroskum
NO20021400D0 (no) Terapeutiske konazolinderivater
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
DK1524266T3 (da) Farmaceutisk sammensætning
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
NO992339D0 (no) Farmas°ytiske formuleringer
FI20011478A0 (fi) Farmaseuttinen koostumus
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20022606L (no) Farmasöytiske kombinasjoner
PT1239832E (pt) Composicoes farmaceuticas
NO20014926D0 (no) Farmasöytiske forbindelser
FI20022128A0 (fi) Farmaseuttinen koostumus
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60129238D1 (de) Pharmazeutische zusammensetzung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
NO20020555L (no) Mikropartikler for lungeadministrering
FI4488U1 (fi) Farmaseuttinen koostumus
ID30249A (id) Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430L (no) Farmasöytisk kompleks